
Some studies have indicated that statins inhibit colorectal carcinogenesis in rodents. And one large case–control study from Israel-the Molecular Epidemiology of Colorectal Cancer (MECC) Trial-found that people who took statins for 5 years or more cut their risk of colorectal cancer in half.
